在新发型1型儿科糖尿病中出现过高甘油三血
Colleen A Macke1, Iman Al-Gadi1, Nidhi Bansal1
1Division of Diabetes and Endocrinology, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas, USA.
Pediatric diabetes
|July 4, 2025
概括
严重的高甘油三血症 (HTG) 在患有新发型1型糖尿病 (T1D) 的儿童中很少见,但可能导致严重的并发症,如胰腺炎. 在这些患者中,早期查和对HTG的监测至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 代谢障碍 代谢障碍 代谢障碍
- 糖尿病是一种糖尿病.
背景情况:
- 由于胰岛素缺乏,高甘油血症 (HTG) 在新发糖尿病中很常见.
- 在患有新发型1型糖尿病 (T1D) 的儿科患者中,严重的HTG (TG > 1000 mg/dL) 是罕见的,且表征不佳.
- 胰岛素缺乏会影响甘油三清除,并促进脂解.
研究的目的:
- 描述患有新发型T1D的儿科患者中严重HTG的发生率和后续情况.
- 审查一个单一中心的经验和文献在这个人群中严重的HTG病例.
- 讨论潜在的查和监测策略.
主要方法:
- 一个单一中心经验 (2013-2022) 的回顾性审查.
- 在文献中搜索先前报告的儿童新发型T1D中严重HTG的病例.
- 分析患者表现,TG水平和相关并发症.
主要成果:
- 在儿科新发型T1D中严重的HTG很少见,但具有可变的临床表现.
- 病例与高风险并发症有关,包括急性胰腺炎.
- 真正的发病率和长期后果需要进一步调查.
结论:
- 在儿科新发型T1D中严重的HTG虽然罕见,但由于潜在的并发症,需要临床关注.
- 建议在患有新发型T1D和长期腹痛的儿科患者进行HTG和胰腺炎的早期查.
- 建议对儿童患者进行密切监测,确定有显著的HTG.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Insulin: Dosing Regimen and Adverse Effects
265
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
265
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications
702
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
702
Diabetes: Management and Pharmacotherapy
408
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
408


